magNews

Corporate Industry Technology Medical Updates

Redefining New Boundaries in Delivering Patient Care

magAssist Recognized in 2024 VENTURE50 Awards

MoyoAssist® Extra-VAD® Introduces Fully Magnetically Levitated Extracorporeal Heart Support Technology in China

MoyoAssist® Launched! The Mid-to-Short-Term MCS Forum and Extra-VAD Clinical Technology Transformation Results Conference Successfully Held

Corporate
magAssist was awarded the title of "Venture 100 Future Unicorn" 2021-12-17
Corporate
magAssist was named a potential unicorn company in Jiangsu Province 2021-12-02
Corporate
Dr. Chiahao Hsu of magAssist named to 2021 Innovative Sci-Tech Leaders of Suzhou New District 2021-12-01
Medical Updates
Percutaneous Ventricular Assist Device Led by Academician Junbo Ge and Jointly Developed by CCI and magAssist Makes Significant Progress 2021-11-11
Corporate
magAssist named to the Jiemian News 2021 "REAL 100 Innovators" List 2021-10-13
Technology
magAssist receives keen international attention at the 47th European Society for Artificial Organs Congress 2021-09-13
Corporate
Suzhou City leaders led a team to observe key projects in Suzhou High-tech Zone and learn more about the development of magAssist 2021-09-06
Medical Updates
Professor Ping Li "Extra-VAD, could be a greater life-support solution for Bridging to Heart Transplantation" 2021-07-30
Medical Updates
The "Extra-VAD" jointly developed by Wuhan Union Medical College and magAssist Inc. was put into clinical use 2021-07-21
Medical Updates
Percutaneous Ventricular Assist Device jointly developed by Ge Junbo’s team of Zhongshan Hospital affiliated to Fudan university and magAssist has made ground-breaking achievements 2021-07-17

Tags： Innovation, Application, Extra-VAD, U.S. FDA, Interventional Ventricular Assist Device, Breakthrough Device, VENTURE50, Awards, Healthcare, Difference,